$SLQT

SelectQuote receives NYSE notice over stock price compliance

SelectQuote Inc. (NYSE: SLQT) received a notice from the NYSE due to its common stock trading below $1.00 per share for 30 consecutive trading days. The company has a six-month cure period to regain compliance, needing its stock to close at or above $1.00 with an average closing price of at least $1.00 over the preceding 30 days. Despite the current low stock price and the delisting notice, InvestingPro analysis suggests the stock may be undervalued, and the company recently reported stronger-than-expected Q2 fiscal year 2026 earnings and launched a new franchise model.

Original reporting
Investing.com · Company News
Published Mar 26, 2026, 1:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 26, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SLQT
Neutral
medium confidence
Mentioned
$SLQT
AlphAI data visualization · based on Investing.com
Decision brief

The 30-second read

$SLQTNeutralMed
01

Why it matters

The delisting notice introduces short-term volatility and potential downside risk. However, positive earnings and strategic moves could support a future rebound, especially if the company addresses compliance issues.

02

Market read

The news is highly relevant for traders holding or considering trading SLQT, with implications for short-term trading strategies and long-term investment considerations.

03

What to watch

Possible regulatory changes or market sentiment shifts that could influence delisting outcomes and stock recovery.

Timing: Immediate to short-term; news published today.

Background

SelectQuote's stock has been trading below $1.00 for over 30 days, triggering NYSE delisting procedures. Despite this, the company reported strong Q2 earnings and is launching new franchise models, which may signal underlying operational strength.

Company-level read

Ticker impact

$SLQTNeutralMedium confidence
Context

Primary focus due to NYSE delisting notice and recent earnings report.

Expected impact

Potential short-term decline due to delisting concerns; possible rebound if company actions restore compliance and investor confidence.

Evidence & confidence

While the delisting risk introduces downside pressure, recent positive earnings and strategic initiatives could lead to a valuation correction. The mixed signals warrant cautious positioning.

Market effects

Potential negative sentiment in the financial services sector due to delisting concerns.

Limited; primarily affects NYSE-listed companies and investors.

Low; specific to US markets and the company's operations.

Counterpoint

The company's recent earnings and strategic initiatives could lead to a recovery in stock price, making current low levels a potential buying opportunity for long-term investors.

Key entities

  • SelectQuote Inc.

    A provider of insurance distribution services, listed on NYSE.

  • NYSE

    New York Stock Exchange, which has issued a delisting notice to SLQT.

Related articles

$SLQTHighAI 8/10

SelectQuote (SLQT) Q4 2026 Earnings Call Transcript

SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.

$SLQTMedAI 8/10

SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line

SelectQuote (SLQT) reported fiscal 2026 revenue of $1.62B, up 6% YoY, with operating cash flow increasing $44M. However, it posted a Q4 net loss of $16.8M and guided fiscal 2027 revenue lower. Healthcare Services revenue grew 14% to $845M, despite drug pricing changes. The company identified $30M in annual savings from AI tools. Guidance expects fiscal 2027 revenue to decline 14% at the midpoint, with Medicare Advantage policies projected to fall further.

$SLQTMedAI 8/10

SelectQuote Q4 Earnings Call Highlights

SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.

$SLQTHighAI 8/10

SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook

SelectQuote (SLQT) shares fell 14.69% in pre-market trading after reporting Q4 fiscal 2026 revenue of $321.7M, missing estimates, and issuing a fiscal 2027 revenue outlook of $1.35B-$1.45B, below consensus. The company reported a net loss of $16.8M, though adjusted EBITDA improved. CEO Tim Danker highlighted success in the Senior Medicare Advantage segment.

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$SLQTHigh

SelectQuote, Inc. (SLQT): Results of Operations and Financial Condition

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results Fourth Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $321.7 million • Net loss of $(16.8) million • Adjusted EBITDA* of $11.9 million Fiscal Year 2027 Guidance Ranges: